Loading clinical trials...
Loading clinical trials...
IMPACT: Improving Access to Cancer Survivorship Via Telehealth
This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.
OUTLINE: Patients complete a questionnaire at baseline (paper, online, or telephone-based) and have medical records reviewed and are assigned to 1 of 3 cohorts. COHORTS A AND B: Patients are randomized to 1 of 2 arms. ARM I: Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses). ARM II: Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors. COHORT C: Patients are randomized to 1 of 3 arms. ARM III: Patients receive generic information on survivorship care on study. ARM IV: Patients receive generic information on survivorship care and a self-generated SCP as in Arm I on study. ARM V: Patients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study. PRIMARY CARE PROVIDERS: Primary care providers complete a questionnaire about perceptions of the SCP and self-efficacy in providing survivorship care. ONCOLOGY CLINICS: Participants complete Organizational Readiness to Change Assessment (ORCA) questionnaire and participate in a qualitative interview about perceptions of implementation of survivorship care. After completion of study, patients are followed up at approximately 8 weeks.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
February 19, 2020
Primary Completion Date
December 31, 2025
Completion Date
March 31, 2026
Last Updated
January 9, 2026
261
ACTUAL participants
Survivorship Care Plan
OTHER
Educational Intervention
OTHER
Questionnaire Administration
OTHER
Supportive Care
OTHER
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
NCT05372640
NCT05673200
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions